Petróleo Brasileiro SA vs Vir Biotechnology Inc. Common Stock — how do they compare? Petróleo Brasileiro SA trades at $25.79 (market cap $159.16B), while Vir Biotechnology Inc. Common Stock trades at $10.38 (market cap $1.76B). The key difference: Petróleo Brasileiro SA is far larger — about 90.4× Vir Biotechnology Inc. Common Stock's market cap, and Petróleo Brasileiro SA pays a 6.46% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Petróleo Brasileiro SA for 26 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| PBR | VIR | |
|---|---|---|
Market Cap | $159.16B | $1.76B |
Volume | 19,717,211 | 2,764,948 |
Sector | Energy | Health |
52-Week High | $25.94 | $11.78 |
52-Week Low | $11.54 | $5.12 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | $219.58B | $1.32B |
Dividend Yield | 6.46% | — |
Signals from Pluang's Aura AI — not financial advice
Petrobras (PBR) trades at $25.50, up 0.31% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong Q2 2026 earnings that beat estimates, with net income nearly doubling year-over-year on record production. Recent news highlights a new oil discovery off Amapa and a 22-year LNG supply deal with Cheniere Energy, supporting long-term growth prospects.
PBR presents a compelling value with a low P/E of 6.44 and robust profitability, including a 30.77% ROE. However, the stock trades above the analyst consensus price target of $22.33, and net cash flow turned negative in 2026. Key risks include political interference in Brazil, volatile oil prices, and execution challenges in new projects.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →